Choriocarcinoma Syndrome: A Potentially Fatal Complication of Testicular Cancer

  • Zeitjian V
  • Arslan W
  • Borja-Alvarez A
  • et al.
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Choriocarcinoma syndrome is a rare clinical entity with advanced, high volume choriocarcinomatous tumors and markedly elevated B-hCG (>50,000 IU/L). Recognition is important because the diagnosis of this syndrome identifies poor prognosis without mortality-proven management options. We present a case of a male in his twenties with metastatic choriocarcinoma who developed choriocarcinoma syndrome acutely after chemotherapy commencement. The patient deceased after hypoxic respiratory failure due to diffuse alveolar hemorrhage as a result of death of vascular tumors. While the prognosis for early diagnosis and treatment is excellent, the prognosis for late diagnosis is grim. Unfortunately, despite surgical or chemotherapeutic intervention, this syndrome has poor outcome.

Cite

CITATION STYLE

APA

Zeitjian, V. S., Arslan, W., Borja-Alvarez, A., & Amar, S. (2019). Choriocarcinoma Syndrome: A Potentially Fatal Complication of Testicular Cancer. Case Reports in Oncological Medicine, 2019, 1–2. https://doi.org/10.1155/2019/4092941

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free